Epstein Secrets

ense lawyers in the 2008 case. Luminaries at Mr. Epstein's St. Thomas conference in 2006 included Mr. Hawking and the Caltech theoretical physicist Kip S. Thome. One participant at that conference, which was ostensibly on the subject of gravity, recalled that Mr. Epstein wanted to talk about perfecting the h

regulators. But in 2017, the company practically beamed that it had "received clearance from the U.S. Food and Drug Administration for the Company's Investigational New Drug (IND) application lodged last month." The fact that Collins' role in the legislation could also have benefited other companies — and may even have been

ense lawyers in the 2008 case. Luminaries at Mr. Epstein's St. Thomas conference in 2006 included Mr. Hawking and the Caltech theoretical physicist Kip S. Thorne. One participant at that conference, which was ostensibly on the subject of gravity, recalled that Mr. Epstein wanted to talk about perfecting the h

regulators. But in 2017, the company practically beamed that it had "received clearance from the U.S. Food and Drug Administration for the Company's Investigational New Drug (IND) application lodged last month." The fact that Collins' role in the legislation could also have benefited other companies — and may even have been

ense lawyers in the 2008 case. Luminaries at Mr. Epstein's St. Thomas conference in 2006 included Mr. Hawking and the Caltech theoretical physicist Kip S. Thome. One participant at that conference, which was ostensibly on the subject of gravity, recalled that Mr. Epstein wanted to talk about perfecting the h

regulators. But in 2017, the company practically beamed that it had "received clearance from the U.S. Food and Drug Administration for the Company's Investigational New Drug (IND) application lodged last month." The fact that Collins' role in the legislation could also have benefited other companies — and may even have been